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The UK has one of the highest methicillin-resistant
Staphylococcus aureus (MRSA) to methicillin-sensitive S.
aureus (MSSA) blood infection rates in Europe.1 Recent data
indicate that MRSA infection is associated with higher mor-
tality rates and is implicated as the causative organism in
28% cases of S. aureus bacteraemia.2,3
Addressing the level of MRSA hospital-acquired infection
(HAI) rates is a major world-wide problem; whilst recent
data have demonstrated a trend towards decreasing num-
bers of MRSA infections,4 screening for MRSA could poten-
tially allow earlier detection of those with MRSA. This may
allow healthcare workers to target resources efficiently in
an attempt to decrease rates of MRSA transmission using
isolation or decolonisation strategies.5
In order to inform these strategies, further research is
urgently required to identify high-risk patient populations
in order to direct efficient screening programmes.
Screening has now been recommended routinely for all
hospital in-patients in some regions;6 however, whilst these
pilot studies will identify the effectiveness of such pro-
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ABSTRACT
INTRODUCTION Methicillin-resistant Staphylococcus aureus (MRSA)-related hospital-acquired infection (HAI) in surgical
patients is associated with high morbidity, mortality and financial cost. The identification and characterisation of populations
of patients who are at high risk of developing MRSA infection or colonisation could inform the design of more effective strate-
gies to prevent HAIs and reduce transmission of MRSA.
PATIENTS AND METHODS An analysis of historical discharge data for the whole of 2005 (7145 surgical in-patients) was per-
formed, for all patients admitted to general surgery at the Royal Infirmary of Edinburgh. Analysis specifically focused on MRSA
laboratory data and coding data for patient demographics, medical co-morbidities, and progress of in-patient stay.
RESULTS A total of 134 (1.88%) individual patients with colonisation or infection by MRSA were identified from indicated
laboratory testing. Univariate analysis identified a significant association of concurrent MRSA-positive status with patients
aged over 60 years (P < 0.01), a duration of inpatient stay > 7 days (P < 0.01), presence of a malignant neoplasm (P <
0.01), circulatory disease (P < 0.01), respiratory disease (P < 0.01), central nervous system disease (P < 0.01), renal failure
(P < 0.01), and concurrent admission to ITU/HDU (P < 0.01). Multivariate analysis suggested MRSA colonisation or infection
was strongest in those with co-morbid malignancy (P < 0.0001) or admission to ITU/HDU (P < 0.0001).
CONCLUSIONS This large observational study has identified cancer patients as a UK surgical patient subpopulation which is at
significantly higher risk of colonisation by MRSA. These data could inform the development of focused hospital in-patient
screening protocols and provide a means to stratify patient risk.
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grammes, there is considerable debate regarding their
expected benefit.7
The aim of this study was to undertake a major evalua-
tion of all MRSA colonisations/infections in surgical in-
patients within 1 year and evaluate the specific patient
characteristics, demographics and variables which would
allow for the identification of a patient subpopulation at
high risk.
Patients and Methods
The study analysed data from all in-patients admitted to the
Royal Infirmary of Edinburgh (RIE) during 2005. This large
university teaching hospital opened in 2003 and serves a
population of approximately 880,000 from south-east
Scotland. The hospital is a tertiary specialist surgical refer-
ral centre for a number of surgical sub-specialities
focussing on upper gastrointestinal and hepatobiliary sur-
gery, with lower gastrointestinal surgery being handled in
another local hospital.
Bacteriological results from all surgical patients admit-
ted to RIE were obtained from the RIE Department of
Microbiology database. Testing at the time of study
occurred only as clinically indicated, with no formal MRSA
screening programme in place. Most commonly, swab sam-
ples were taken from the nose, throat, axilla and groin, with
further samples taken from areas which appeared clinical-
ly infected. Colonised or infected patients were identified by
a positive MRSA culture using conventional microbiological
techniques for growth on blood agar plates. MRSA colonisa-
tion and infection status were defined as a positive MRSA
culture within 24 h of discharge from the surgical admis-
sion, to take into account time taken to process positive
samples in the laboratory.
The surgical patient population was identified between 1
January 2005 and 31 December 2005, associated with a par-
ticular surgical ward/intensive care ward/consultant, taken
from the hospital computerised Patient Admission System
(PAS) database. Duplicate admissions for each patient were
deleted from this list. Additional simultaneous analysis of
the Hospital Activities Coding database was performed to
obtain details of patient specific relevant International
Classification of Disease (ICD)-10 and Office of Population,
Censuses and Surveys (OPSC)-4 codes recorded for each
surgical admission. Only patients present on all three data-
base interrogations were included in the analysis.
Importantly, in order to detect only those who would be a
high risk of infection within the hospital environment,
patients who had become MRSA infected/colonised outside
the duration of their surgical admission were excluded
from analysis.
Patient variables such as sex, date of birth, date of admis-
sion and discharge, postcode, admitting ward, ITU/HDU
stay during admission, ICD-10 code, and date of positive
MRSA culture were recorded from the databases on a
Microsoft Office 2004 Excel worksheet and transferred to
SAS v.9.1 for later statistical analysis.
For categorical variables such as sex, chi-squared and
Fisher’s exact tests were used as appropriate. To determine
if there was any difference in age by MRSA status, a two-
sample t-test was performed. The data for length of stay
were not normally distributed; therefore, a Mann–Whitney
test was used. The value of 0.05 was taken to define statisti-
cal significance. In order to take multiple variables into
account, a logistic regression on appropriate variables has
been performed.
Ethical approval was obtained through The University of
Edinburgh; statistical analysis was performed with the help
of the Epidemiology and Statistics Core, University of
Edinburgh, Wellcome Trust Clinical Research Facility,
Western General Hospital Edinburgh.
Results
A total of 7145 patients were admitted to the speciality of
general surgery in 2005. Laboratory databases confirmed
that 134 (1.88%) patients were found to be
colonised/infected with MRSA. Within this group were 72
(1.01%) cases of colonisation and 62 (0.87%) cases of infec-
tion, of which 21 (0.29%) were cases of MRSA bacteraemia.
The mean age of MRSA positive patients was 59.8 years
(range, 16–95 years SD 15.6) compared to the mean age of
49.5 years (range, 12–101 years; SD 20.3) for surgical admis-
sions with no evidence of MRSA infection/colonisation (P <
0.001).
There were 3139 (44.8%) males compared to 3872 (55.2%)
females in the non-infected or colonised group and 69
(51.5%) males and 65 (48.5%) females in the MRSA infect-
ed/colonised group. Sex was not associated with MRSA
colonisation/infection (P = 0.12 using a chi-squared test).
Social deprivation was evaluated crudely based on the
2001 Carstairs Deprivation Category (depcat score)8 using
the patient’s postal code. Using a chi-squared test, there was
no evidence of an association between MRSA infection or
colonisation and depcat score (P = 0.57).
Univariate analysis of co-morbidities demonstrated a
significant association between infection/colonisation with
MRSA and malignant disease (P < 0.001). Of patients with a
cancer diagnosis, 10.4% (44) tested positive for MRSA com-
pared to 1.3% (90) of patients without a diagnosis of malig-
nancy. In particular, carcinoma of the oesophagus (P <
0.001 using Fisher’s exact test), and pancreatic cancer (P =
0.022 using Fisher’s exact test) were significantly associat-
ed with MRSA infection and colonisation. Additional co-
morbidities including circulatory disease (P < 0.01), respira-
tory disease (P < 0.01), CNS disease (P < 0.01), renal failure
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(P < 0.001), diabetes mellitus (P = 0.028) and infectious or
parasitic disease (other than MRSA; P = 0.001) were identi-
fied as being strongly associated with MRSA infection or
colonisation. However, gastrointestinal and genito-urinary
disease did not demonstrate a statistically significant link
with MRSA infection and colonisation (P = 0.074 and P =
0.3471, respectively).
In common with other studies, admission to ITU or HDU
was significantly associated with MRSA infection and
colonisation (P < 0.001). While only 7.2% (508) have non-
infected or colonised patients admitted to ITU/HDU, 60.4%
(81) of those infected or colonised with MRSA were admit-
ted to ITU/HDU during their hospital stay (Table 1).
Of the MRSA-positive patients, 92 (68.7%) had a duration
of in-patient stay greater than a week, compared to 1060
(15.1%) of the non-colonised or infected patients. Using a
chi-squared test for linear trend, there was evidence of a
linear trend between MRSA and length of stay when it is
treated as a categorical variable (same day, 1–2, 3–7, 8–30,
> 30 days; P < 0.001). The median length of stay for those
with MRSA infection/colonisation was 14 days, compared to
2 days in patients without MRSA (P < 0.0001 using a
Mann–Whitney test).
Using those variables which reached statistical signifi-
cance or which had a P-value of less than 0.1 on the single
variable analysis, a logistic regression model was produced.
Although CNS disease, diabetes and pancreatic cancer
reached statistical significance at the 5% level in the uni-
variate analysis, they were not been included in the multi-
variable analysis due to small patient numbers. Evidence
from the regression model suggested that circulatory dis-
ease, digestive disease, oesophageal cancer, malignant neo-
plasm or being in ITU/HDU independently increase the risk
of developing MRSA colonisation or infection (Table 2).
Discussion
The introduction of a UK-wide, risk-stratified policy for the
management of MRSA in 1998 has done little to halt the
spread of MRSA.9 However the UK, France and Slovenia
may be reversing the trend and have recently reduced the
rates of MRSA to MSSA bacteraemia.10 A recent review of the
clinical and cost-effectiveness of MRSA screening has
emphasised the importance of the identification of patients
at high risk of infection with MRSA, but found that the cost
of universal screening is prohibitively high.11 A better
understanding of risk factors might allow a more focused
approach to screening.
Here, we have identified several risk factors associated
with MRSA infection and colonisation which have already
contributed to changes in infection control policies at the
RIE. In particular, we identified that carcinoma of the
oesophagus is a specific risk factor for MRSA infection and
colonisation. This is significant, as patients with head and
neck cancer who develop MRSA infection have been shown
to have increased surgical morbidity and mortality.12
Further research has implicated neoplasia as an independ-
ent risk factor for mortality from nosocomial S. aureus bac-
teraemia.13 Health economy issues are also relevant given
the high costs associated with hospital stay for oncology
patients.14 This has changed the policy at the RIE by focus-
ing more attention to the regular screening of patients with
oesophageal cancer.
The reasons for the link between MRSA acquisition and
malignant disease are likely to be multifactorial and have
been examined in other research. Several recent reviews
have identified the relationship between cachexia, low
serum albumin and the systemic inflammatory response as
Variable Odds 95% CI P-value
ratio (lower; upper)
Circulatory disease 1.8294 (1.1763, 2.8451) 0.0074
Digestive disease 1.5770 (1.0560, 2.3549) 0.0260
Oesophageal cancer 4.3614 (1.9902, 9.5581) 0.0002
Malignant neoplasm 3.9232 (2.3800, 6.4669) <0.0001
ITU/HDU admission 13.0241 (8.9098, 19.0383) <0.0001
Table 2 Multivariate regression analysis of risk factors
Variable Chi-squared P-value
Sex 2.40 0.1213
Circulatory disease 39.87 < 0.0001
Respiratory disease 18.38 < 0.0001
Digestive disease 3.19 0.0740
Renal failure 29.78 < 0.0001*
Genito-urinary disease 0.88 0.3471
Previous infection 13.85 0.0013*
CNS disease 16.13 0.0024*
Pancreatic cancer 8.26 0.022*
Oesophageal cancer 255.28 <0.001*
Malignant neoplasm 177.63 <0.001
Diabetes mellitus 5.82 0.0279*
ITU/HDU 492.03 < 0.0001
Deprivation score 4.81 0.5683
*Using Fisher’s exact test due to small expected counts.
Table 1 Univariate analysis of risk factors
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significant prognostic and predictive factors in cancer
patients.15,16 It can be hypothesised that tumours associated
with high rates of anorexia and rapid weight loss (such as
oesophageal and pancreatic cancer) confer a poorer prog-
nosis and increased susceptibility to MRSA infection.
Further supportive evidence has shown that patients had a
reduced ability to produce anti-pneumococcal polysaccha-
ride IgG following oesophageal surgery, leaving them more
prone to MRSA infections.17 Prospective study suggested
that the application of mupirocin calcium hydrate ointment
to the nasal cavity,18 and the use of pre-operative antimicro-
bial therapy may reduce the incidence of MRSA infection in
high-risk patients.19
Previous research has shown that patients over 60 years of
age who are infected with S. aureus have significantly higher
rates of mortality compared to younger patients,20 and surgical
site infections (SSIs) are associated with poorer functional sta-
tus in elderly patients.21 Patients with respiratory, circulatory
and central nervous system (CNS) disease were also identified
as at significant risk of being colonised or infected with MRSA.
Previous reports have linked chronic illness to increased risk
of both community-acquired22 and hospital-acquired MRSA
infection.23 In particular, respiratory diseases,24 circulatory dis-
eases25 and CNS diseases26 have previously been linked with S.
aureus infections.
While initial univariate analysis failed to demonstrate a sig-
nificant association between MRSA colonisation/infection and
digestive disease, further multivariate analysis established
that, when all other factors were taken into account, there was
a significant association to the 5% level. The discrepancy is
likely due to the high load of gastrointestinal patients (> 50%)
admitted during our period of study to the RIE, complicating
the initial analysis. This association is supported in further
research demonstrating a significant association between
recent gastrointestinal disease and MRSA colonisation.27
In-patient stay is significantly associated with increased
risk of infection and colonisation with MRSA. Research from
the US has also demonstrated that MRSA infection was
linked with increased length of hospitalisation when com-
pared to uninfected patients.28 It is unclear, however, if
length of hospital stay is the cause of MRSA transmission, or
whether it is part of the sequelae of infection. Further inves-
tigation of this issue is likely to be complicated, as identify-
ing the cause and timing of infection is notoriously difficult.
However, from a pragmatic perspective, the screening of
patients with prolonged hospital stay may help reduce rates
of transmission in either clinical situation. The timing of
this screening requires further clarification; however, hos-
pital stay greater than 7 days may be a benchmark for future
prospective study.
While ITU/HDU stay is evidently associated with
increased rates of MRSA, what requires further clarification
is the timing of colonisation and infection with regards to
ITU/HDU admission. One study found 6.8% of patients
screened on admission to ITU were colonised with MRSA,
with a further 11.4% becoming colonised during their ITU
admission. The risk of infection increased proportionally
with duration of admission.29 The inability to discern the
point of patient colonisation or infection with MRSA, howev-
er, presents a limitation to the interpretation of these
results; it is for this reason that current prospective
research is underway to investigate the stage at which
MRSA acquisition occurs in surgical patients admitted to
ITU/HDU.
Study limitations
The most significant limitation of this retrospective data
analysis is the inability to examine other known MRSA-asso-
ciated variables such as prior hospital admission, antibiotic
prescriptions and residence (i.e. long-term nursing care); fur-
ther study would aim to include this information for analysis.
Furthermore, the total number of cases of MRSA has been
under-represented due to the lack of a screening programme
in place during 2005 at the RIE and the transfer of infected or
colonised patients from the RIE surgical wards to those wards
not included in our initial database search. Additionally, our
lack of patient data post-discharge, particularly for those
patients undergoing minor surgery, means cases of MRSA
presenting after discharge were not available for evaluation.
All of these factors are likely to have contributed to an under-
estimation of the true incidence of MRSA infection and coloni-
sation at the RIE during 2005. In addition, the changing epi-
demiology of MRSA and the identification of community-
acquired cases is an important issue. However, as this study
was concerned only with reducing transmission within the
hospital setting, we aimed to exclude confounding communi-
ty associated factors. Further prospective study would aim to
examine this.
Conclusions
These data identify specific subpopulations of surgical patients
that are at higher risk of MRSA infection/colonisation. This is
particularly relevant in patients with malignancy. We propose
that factors including malignancy, circulatory disease, diges-
tive disease, ITU admission or in-patient length of stay be
included in future risk stratification for targeted screening to
detect those who have MRSA infection/colonisation. Increased
education and surveillance of cancer patients within the hos-
pital environment may help to decrease MRSA-associated
morbidity and mortality.
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